Educational information, not medical advice — ask your doctor or midwife.
Honokiol is a polyphenol compound found in the bark and leaves of magnolia trees, particularly Magnolia officinalis and Magnolia grandiflora. It has been a key ingredient in Hou Po, a traditional Chinese and Japanese herbal remedy used for over 2,000 years to ease anxiety, digestive upset, and restlessness. In recent decades, researchers have been studying it intensively for its remarkable range of biological effects, including calming the nervous system, reducing inflammation, and protecting brain cells.
Honokiol works primarily by interacting with GABA receptors in the brain — the same calming receptors targeted by anti-anxiety medications — helping to quiet an overactive nervous system. It also acts as a potent antioxidant and reduces inflammatory signaling throughout the body. It is described as crossing the blood-brain barrier, and it is commonly used for brain-related applications like anxiety, cognitive protection, and sleep.
Honokiol is most commonly taken as a capsule or soft gel, with doses typically standardized to honokiol content. Liquid extracts and tinctures are available for those who prefer flexible dosing. Topical preparations containing magnolia extract are used in skincare for their antioxidant and soothing properties. Liposomal formulations are emerging in research settings to improve absorption.
Magnolia bark (Hou Po) has been used in Traditional Chinese Medicine and Japanese Kampo for over 2,000 years, classically prescribed for anxiety, digestive bloating, and emotional disturbance. Honokiol was first isolated and identified as a distinct compound in the 20th century, and modern pharmaceutical and nutraceutical research has expanded its potential applications considerably beyond its traditional roots.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.